You are here

bladder cancer

After Padcev combo’s major triumph, Merck’s Keytruda delivers partial win in bladder cancer

Fierce Pharma

Fri, 01/26/24 - 12:03 pm

Johnson & Johnson wins full FDA approval for bladder cancer therapy Balversa

Seeking Alpha

Sun, 01/21/24 - 05:11 pm

urothelial cancer

CG Oncology aims for $209M IPO, as more biotechs eye path to public markets

Fierce Biotech

Thu, 01/18/24 - 11:11 am

CG Oncology plans IPO plunge ahead of phase 3 bladder cancer drug readout

Fierce Biotech

Wed, 01/3/24 - 09:35 am

Merck, Astellas and Pfizer bring down the house with Keytruda-Padcev FDA nod in bladder cancer

Fierce Pharma

Tue, 12/19/23 - 10:26 am

BMS chases Merck/Seagen with first-line bladder cancer filing

Pharmaphorum

Tue, 12/5/23 - 11:53 pm

Bristol Myers Squibb

urothelial cancer

FDA starts review of Padcev/Keytruda for bladder cancer

Pharmaphorum

Fri, 12/1/23 - 09:35 am

priority review

Merck, BMS Score Separate Late-Stage Victories in Bladder Cancer at ESMO

BioSpace

Mon, 10/23/23 - 05:15 pm

Bristol Myers Squibb

PD-1 inhibitors

ESMO: Bristol Myers' Opdivo chalks up bladder cancer win. But a rival combo casts long shadow

Fierce Pharma

Sun, 10/22/23 - 06:06 pm

Bristol Myers Squibb

ESMO: Seagen, Astellas and Merck knock it out of the park with Padcev-Keytruda combo in bladder cancer

Fierce Pharma

Wed, 10/18/23 - 11:42 am

Merck eyes new bladder cancer space with positive Keytruda trial in muscle-invasive disease

Fierce Pharma

Thu, 10/5/23 - 09:03 pm

muscle-invasive urothelial carcinoma

Merck, Seagen and Astellas Get Late-Stage Win in Bladder Cancer with Combo

BioSpace

Fri, 09/22/23 - 11:53 am

urothelial cancer

clinical trials

Royalty Pharma to Pay Potential $500M for Royalties on Ferring’s Gene Therapy

BioSpace

Thu, 08/24/23 - 08:34 pm

Ferring Pharmaceuticals

CG brings back the crossover round, reeling in $105M to fund phase 3 bladder cancer trial

Fierce Biotech

Wed, 08/2/23 - 11:30 am

clinical trials

Urogen's Potential First Non-Surgical Therapy for LG-IR-NMIBC Posts Promising Phase 3 Trial Data

Benzinga

Thu, 07/27/23 - 11:35 am

clinical trials

non-muscle invasive bladder cancer

Bristol Myers' Opdivo stages comeback in bladder cancer, teeing up 2 'Merck' showdowns

Fierce Pharma

Wed, 07/12/23 - 09:30 am

Bristol Myers Squibb

Ferring, with manufacturing update, takes a step towards first gene therapy sales

BioPharma Dive

Wed, 06/14/23 - 10:07 am

Ferring Pharmaceuticals

Lilly, Takeda Face Class-Action Racketeering Lawsuit Over Diabetes Drug

BioSpace

Thu, 06/8/23 - 10:13 am

ASCO: Johnson & Johnson's Balversa tops chemotherapy in bladder cancer trial

Fierce Pharma

Mon, 06/5/23 - 10:02 pm

AstraZeneca study points to new uses for targeted cancer drug Enhertu

BioPharma Dive

Mon, 06/5/23 - 11:32 am

cervical cancer

Pages